Corbus Pharmaceuticals (CRBP)
(Delayed Data from NSDQ)
$42.99 USD
-0.75 (-1.71%)
Updated May 10, 2024 04:00 PM ET
After-Market: $42.90 -0.09 (-0.21%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-1.41 | 0.00% |
Earnings Summary
For their last quarter, Corbus Pharmaceuticals (CRBP) reported earnings of -$0.83 per share, beating the Zacks Consensus Estimate of $-1.09 per share. This reflects a positive earnings surprise of 23.85%. Look out for CRBP's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$1.41 per share, reflecting a year-over-year increase of 31.22%.
Earnings History
Price & Consensus
Zacks News for CRBP
What Makes Corbus Pharmaceuticals (CRBP) a Good Fit for 'Trend Investing'
CRBP: What are Zacks experts saying now?
Zacks Private Portfolio Services